Sanofi
Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic solutions across the United States, Europe, and numerous international markets. The company strategically organizes its operations into three core…
1D
+0.8%
1W
+1.3%
1M
-4.6%
6M
-15.5%
YTD
-16.2%
1Y
-18.8%
2Y
-25.4%
5Y
-16.9%
10Y
+7.6%
Next earnings date
30/10/2026 (in 13 days)
Volatility around earnings
~49% stronger price swings than usual
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Register for free
Unlock all 11 scores
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
PRICE TARGET LOW
US$49.00
CONSENSUS
US$49.50
MEDIAN
US$49.50
PRICE TARGET HIGH
US$50.00
0
STRONG BUY
12
BUY
14
HOLD
1
SELL
0
STRONG SELL
27
TOTAL · Hold
As of: 01/05/2026
P/E
22
P/B
1.24
EV/EBITDA
7.4
RETURN ON EQUITY
0.5%
NET MARGIN
2.8%
DEBT/EQUITY
0.34
DIVIDEND YIELD
11.6%
AS OF
30/06/2026
FREE FLOAT
90.2%
FLOAT SHARES
2,160,286,184
AVG. DAILY VOLUME (30D)
3,147,695
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +0.8%
Forums (Reddit)
Register for free
Register now to see which funds are invested
Sanofi is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in France.
The CEO is Belén Garijo López, the company employs around 76,493 people.
The IPO was on 01/07/2002; the stock trades on NASDAQ under the ticker SNY.
27 analysts rate the stock, the consensus is Hold (as of 01/05/2026).
The average price target is US$49.50, ranging from US$49.00 to US$50.00, with a median of US$49.50.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 30/10/2026.
Around past earnings, price swings were roughly 49% stronger than usual.
Yes. The last dividend was US$2.42 per share, ex-date 04/05/2026, paid on 03/06/2026.
The dividend yield is 11.6% (as of 30/06/2026).
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Roche Holding, Amgen, Gilead Sciences and Pfizer.
Clicking "Analyze stock" lets five strategies assess Sanofi against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.